Abstract
Recent advances in molecular biology and transgenic techniques have led us to better understand the mechanisms of atherosclerosis (Ross, 1999; Lusis, 2000). Oxidative modification of lipoproteins in vascular wall has been considered to trigger the initiation and development of atherosclerosis (Halliwell, 1994; Thomas, 2000; Tomasian et al., 2000). To inhibit these oxidative processes, exogenous antioxidants such as vitamin E and vitamin C or endogenous enzymes such as superoxide dismutase, catalase and glutathione peroxidases have been challenged in various experimental studies and mega-clinical trials. However, since clinical benefits elicited from these antioxidants have been inconsistent (Steinberg, 1995; Yusuf et al., 2000; Stephens et al., 1996), more potent and reliable antioxidants which reduce vascular events, are desired at present.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agarwal, A., Balla, J., Balla, G., Croatt, A.J., Vercellotti, G.M., and Nath, K.A., 1996. Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL.Am J Physiol 271 (4 Pt 2), F814.
Agarwal, A., Shiraishi, F., Visner, G.A., and Nick, H.S., 1998. Linoleyl hydroperoxide transcriptionally upregulates heme oxygenase-1 gene expression in human renal epithelial and aortic endothelial cells. J Am Soc Nephrol 9(11), 1990.
Amit, Y. and Boneh, A., 1993. Bilirubin inhibits protein kinase C activity and protein kinase C-mediated phosphorylation of endogenous substrates in human skin fibroblasts. Clin Chim Acta 223 (1-2), 103.
Balla, G., Jacob, H.S., Balla, J., Rosenberg, M., Nath, K., Apple, F., Eaton, J.W., and Vercellotti, G.M., 1992. Ferritin: A cytoprotective antioxidant stratagem of endothelium. J Biol Chem 267 (25), 18148.
Battish, R., Cao, G.Y., Lynn, R.B., Chakder, S., and Rattan, S., 2000. Heme oxygenase-2 distribution in anorectum: colocalization with neuronal nitric oxide synthase. Am J Physiol 278 (1), G148.
Duckers, H.J., Boehm, M., True, A.L., Yet, S.F., San, H„ Park, J.L., Webb, R.C., Lee, M.E., Nabel, G.J., and Nabel, E.G., 2001. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7 (6), 693.
Halliwell, B., 1994. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344 (8924), 721.
Hayashi, S., Takamiya, R., Yamaguchi, T., Matsumoto, K., Tojo, S.J., Tamatani, T., Kitajima, M., Makino. N., Ishimura, Y., and Suematsu, M., 1999. Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ Res 85 (8), 663.
Hopkins, P.N., Wu, L.L., Hunt, S.C., James, B.C., Vincent, G.M., and Williams, R.R., 1996. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 16 (2), 250.
Hulea, S.A., Wasowicz, E., and Kummerow, F.A., 1995. Inhibition of metal-catalyzed oxidation of lowdensity lipoprotein by free and albumin-bound bilirubin. Biochim Biophys Acta 1259 (1), 29.
Ishikawa, K., Takeuchi, N., Takahashi, S., Matera, K.M., Sato, M., Shibahara, S., Rousseau, D.L., Ikeda-Saito, M., and Yoshida, T., 1995. Heme oxygenase-2: Properties of the heme complex of the purified tryptic fragment of recombinant human heme oxygenase-2. J Biol Chem 270 (11), 6345.
Ishikawa, K., Navab, M., Leitinger, N., Fogelman, A.M., and Lusis, A.J., 1997. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J Clin Invest 100 (5) 1209.
Ishikawa, K., Sugawara, D., Wang, W.-P., Suzuki, K., Itabe, H., Maruyama, Y., and Lusis, A.J., 2001. Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL receptor knockout mice. Circ Res 88 (5), 506.
Ishikawa, K., Sugawara, D., Goto, J., Watanabe, Y., Kawamura, K., Shiomi, M., Itabe, H., and Maruyama, Y., 2001. Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 104 (15), 1831.
Kita, T., Nagano, Y., Yokode, M., Ishii, K., Kume, N., Ooshima, A., Yoshida, H., and Kawai, C., 1987. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 84 (16), 5928.
Liao, F., Andalibi, A., deBeer, F.C., Fogelman, A.M., and Lusis, A.J., 1993. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91 (6), 2572.
Lusis, A.J., 2000. Atherosclerosis. Nature 407 (6801), 233.
Maines, M.D., 1997. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37, 517.
McCoubrey, W.K., Huang, T.J., and Maines, M.D., 1997. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247 (2), 725.
Morita, T., Perrella, M.A., Lee, M., and Kourembanas, S., 1995. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92 (5), 1475.
Morita, T., Mitsialis, S.A., Koike, H., Liu, Y., and Kourembanas, S., 1997. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J Biol Chem 272 (52), 32804.
Motterlini, R., Gonzales, A., Foresti, R., Clark, J.E., Green, C.J., and Winslow, R.M., 1998. Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 83 (5), 568.
Motterlini, R., Foresti, R., Bassi, R., Calabrese, V., Clark, J.E., and Green, C.J., 2000. Endothelial heme oxygenase-1 induction by hypoxia. Modulation by inducible nitric-oxide synthase and Snitrosothiols. J Biol Chem 215 (18), 13613.
Nakayama, M., Takahashi, K., Komaru, T., Fukuchi, M., Shioiri, H., Sato, Ki., Kitamuro, T., Shirato, K., Yamaguchi, T., Suematsu, M., and Shibahara, S., 2001. Increased expression of heme oxygenase-1 and bilirubin accumulation in foam cells of rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 21(8), 1373.
Neuzil, J. and Stocker, R., 1994. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha- tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 269 (24), 16712.
Oberle, S., Schwartz, P., Abate, A., and Schroder, H., 1999. The antioxidant defense protein ferritin is a novel and specific target for pentaerithrityl tetranitrate in endothelial cells. Biochem Biophys Res Commun 261 (1), 28.
Otterbein, L.E., Bach, F.H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R.J., Flavell, R.A., and Choi, A.M.K., 2000. Carbon monoxide has anti-inflammatory effects involving the mitogenactivated protein kinase pathway. Nat Med 6 (4), 422.
Pang, J.H., Jiang, M.J., Chen, Y.L., Wang, F.W., Wang, D.L., Chu, S.H., and Chau, L.Y., 1996. Increased ferritin gene expression in atherosclerotic lesions. J Clin Invest 97 (10), 2204.
Prabhakar, N.R., 1998. Endogenous carbon monoxide in control of respiration. Respir Physiol 114 (1), 57.
Ross, R., 1999. Atherosclerosis-an inflammatory disease. N Engl J Med 340 (2), 115.
Schwertner, H.A., Jackson, W.G., and Tolan, G., 1994. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 40 (1), 18.
Seki, T., Naruse, M., Naruse, K., Yoshimoto, T., Tanabe, A., Tsuchiya, K., Hirose, S., Imaki, T., Nihei, H., and Demura, H., 1997. Roles of heme oxygenase/carbon monoxide system in genetically hypertensive rats. Biochem Biophys Res Commun 241 (2), 574.
Sharma, V.S. and Magde, D., 1999. Activation of soluble guanylate cyclase by carbon monoxide and nitric oxide: a mechanistic model. Methods 19 (4), 494.
Shi, W., Wang, N.J., Shih, D.M., Sun, V.Z., Wang, X., and Lusis, A.J., 2000. Determinants of atherosclerosis susceptibility in the C3H and C57BL/6 mouse model: evidence for involvement of endothelial cells but not blood cells or cholesterol metabolism. Circ Res 86 (10), 1078.
Steinberg, D., 1995. Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? Lancet 346 (8966), 36.
Stephens, KG, Parsons, A., Schofield, P.M., Kelly, F., Cheeseman, K., and Mitchinson, M.J., 1996. Randomised controlled trial of vitamin E in patients with coronary disease. Lancet 347 (9004), 781.
Stocker, R., Yamamoto, Y., McDonagh, A.F., Glazer, A.N., and Ames, B.N., 1987. Bilirubin is an antioxidant of possible physiological importance. Science 235 (4792), 1043.
Stone, J.R. and Marietta, M.A., 1994. Soluble guanylate cyclase from bovine lung: Activation of nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 33 (18), 5636.
Stroes, E.S., Koomans, H.A., de Bruin, T.W., and Rabelink, T.J., 1995. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 346 (8973), 467.
Suematsu, M. and Ishimura, Y., 2000. The heme oxygenase-carbon monoxide system: a regulator of hepatobiliary function. Hepatology 31 (1), 3.
Tenhunen, R., Marver, H.S., and Schmid, R., 1969. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem 244 (23), 6388.
Thomas, M.J., 2000. Physiological aspects of low-density lipoprotein oxidation. Current Opin Lipid 11 (3), 297.
Tomasian, D., Keaney, J.F., and Vita, J.A., 2000. Antioxidants and the bioactivity of endothelium-derived nitric oxide. Cardiovasc Res 47(3) 426.
Tyrrell, R., 1999. Redox regulation and oxidant activation of heme oxygenase-1. Free Rad Res 31 (4), 335.
Wagner, C.T., Durante, W., Christodoulides, N., Heliums, J.D., and Schafer, A.I., 1997. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J Clin Invest 100 (3), 589.
Wang, L.J., Lee, T.S., Lee, F.Y., Pai, R.C., and Chau, L.Y., 1998. Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152 (3), 711.
Wang, R. and Wu, L., 1997. The chemical modification of KCa channels by carbon monoxide in vascular smooth muscle cells. J Biol Chem 272 (13), 8222.
Wu, T.W., Fung, K.P., and Yang, C.C., 1994. Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than trolox. Life Sciences 54 (25), 477.
Yamaguchi, M., Sato, H., and Bannai, S., 1993. Induction of stress proteins in mouse peritoneal macrophages by oxidized low-density lipoprotein. Biochem Biophys Res Commun 193 (3), 1198.
Yamaguchi, T., Horio, F., Hashizume, T., Tanaka, M., Ikeda, S., Kakinuma, A., and Nakajima, H., 1995. Bilirubin is oxidized in rats treated with endotoxin and acts as a physiological antioxidant synergistically with ascorbic acid in vivo. Biochem Biophys Res Commun 214 (1), 11.
Yan, S.D., Schmidt, A.M., Anderson, G.M., Zhang, J., Brett, J., Zou, Y.S., Pinsky, D., and Stern, D., 1994. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269 (13), 9889.
Yoshida, T. and Kikuchi, G., 1978. Purification and properties of heme oxygenase from pig spleen microsomes. J Biol Chem 253 (12), 4224.
Yusuf, S., Dagenais, G., Pogue, J., Bosch, J., and Sleight, P., 2000. Vitamin E supplementation and cardiovascular events in high-risk patients. New Eng J Med 342 (3), 154.
Zakhary, R., Poss, K.D., Jaffrey, S.R., Ferris, C.D., Tonegawa, S., and Snyder, S.H., 1997. Targeted gene deletion of heme oxygenase 2 reveals neural role for carbon monoxide. Proc Natl Acad Sci USA 94 (26), 14848.
Zhang, S.H., Reddick, R.L., Addievich, E., Surles, L.K., Jones, R.G., Reynolds, IB., Quarfordt, S.H., and Maeda, N., 1997. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice. J Clin Invest 99 (12), 2858.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ishikawa, K. (2002). Anti-Atherogenic Properties of Heme Oxygenase. In: Abraham, N.G. (eds) Heme Oxygenase in Biology and Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0741-3_25
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0741-3_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5219-8
Online ISBN: 978-1-4615-0741-3
eBook Packages: Springer Book Archive